For the first time, a company started by East Carolina University faculty members has received a Phase II Small Business Technology Transfer (STTR) grant from the National Institutes of Health.
RFPi, a Greenville medical device company, was awarded $1.49 million for continued development of technology that will be used to evaluate patients with peripheral arterial disease (PAD), a subset of vascular disease that affects blood flow to the lower extremities.
Patients with PAD are at increased risk for heart attack or stroke; left untreated, the condition can lead to the loss of a leg. About 20 million patients in the United States have PAD.
Originally published Oct. 9, 2019.